Assessment of Relations between Clinical Outcome of Ischemic Stroke and Activity of Inflammatory Processes in the Acute Phase Based on Examination of Selected Parameters
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background and Purposes: Inflammatory factors play an important role in the pathogenesis of ischemic stroke. They may influence circulation during the acute phase of stroke and enhance the ischemic region. Materials and Methods: We examined 51 patients – 36 patients in the early stage of stroke, i.e. the first 24 h after onset. Of these, 15 patients had infection and 21 had no infection during the week preceding stroke. There were 15 patients with noninflammatory diseases in the control group. We analyzed parameters of inflammation such as: activity of serum chitotriosidase by fluorimetric assay, C-reactive proteins (CRP), number of white body cells (WBCs), IgG and fibrinogen. We also assessed the neurological stage according to the Scandinavian Stroke Scale (SSS). Results: In our study, we observed a statistically significant difference (p < 0.05) in the activity of most parameters of inflammation. This difference could be seen in the levels of CRP, number of WBCs and the activity of chitotriosidase, apart from IgG and fibrinogen, between the control group and groups with versus without infection. A significantly increased level of CRP (p < 0.0005) and fibrinogen (p > 0.01) was found on the first day in the stroke group as compared to the control group. The neurological stage on day 4 after stroke, assessed according to the SSS, was significantly worse in the group of patients with infection before stroke than in stroke patients without infection (p < 0.008). Conclusion: These results suggest the importance of active inflammatory processes in the pathogenesis of stroke. We observed increased activity of chitotioridase, a parameter of the inflammatory process, in stroke. This study is one more proof that inflammatory processes caused by infection may influence the occurrence of stroke and worsen its outcome. It could be another step towards understanding immunological processes during the acute phase of stroke. The study may also help establish new diagnostic and therapeutic strategies and could be a useful tool for prophylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Hollak, C. E., van Weely, S., van Oers, M. H., & Aerts, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117084 · Cited by 896
Czartoryska, B., Fiszer, U., & Lugowska, A. (2001) · LaboratoriumsMedizin · doi:10.1515/labm.2001.25.3-4.77 · Cited by 3
Self-citation
Cited by
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172
“(2016), http://dx.doi.org/ mental models (Denes et al., 2011), and is borne out by clinical outcomes (Palasik et al., 2005).”
Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms
Huang, X., Hussain, B., & Chang, J. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13569 · Cited by 709
Role of Inflammation and Its Mediators in Acute Ischemic Stroke
Jin, R., Liu, L., Zhang, S., Nanda, A., & Li, G. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9508-6 · Cited by 418
Acute ischaemic stroke and infection: recent and emerging concepts
Emsley, H. C., & Hopkins, S. J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70061-9 · Cited by 416
McColl, B. W., Rothwell, N. J., & Allan, S. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5376-06.2007 · Cited by 337
“In particular, considerable clinical data indicate that acute and chronic systemic infection are risk factors for stroke and are associated with less favorable clinical outcome (Grau et al., 1995a,b; Smeeth et al., 2004; Palasik et al., 2005).”
BackgroundSystemic infection, inflammation and acute ischemic stroke
McColl, B. W., Allan, S. M., & Rothwell, N. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.019 · Cited by 318
McColl, B. W., Rothwell, N. J., & Allan, S. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2674-08.2008 · Cited by 314
King, P. T. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0068-z · Cited by 269
Biomarker of Neuroinflammation in Parkinson’s Disease
Liu, T.-W., Chen, C.-M., & Chang, K.-H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084148 · Cited by 259
Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier
Doll, D. N., Hu, H., Sun, J., Lewis, S. E., Simpkins, J. W., & Ren, X. (2015) · Stroke · doi:10.1161/strokeaha.115.009099 · Cited by 202
“Discussion Acute systemic infection is a risk factor or trigger for human stroke(5,6) and is associated with worsened clinical outcome.(20) Although much is known about the factors that worsen stroke severity in clinical subjects and experimental stroke models, less is understood about their mechanisms.”
BackgroundIntrathecal chitotriosidase and the outcome of multiple sclerosis
Sotgiu, S., Barone, R., Arru, G., Fois, M. L., Pugliatti, M., Sanna, A., Rosati, G., & Musumeci, S. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070614 · Cited by 33
“In physiological conditions Chit production is influenced by demographic factors including age and race [8,9,13,14].”
Background
Metadata
- Authors
- Palasik, W., Fiszer, U., Lechowicz, W., Czartoryska, B., Krzesiewicz, M., & Lugowska, A.
- Venue
- European Neurology
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 53
- Issue
- 4
- Pages
- 188-193
- ISSN
- 0014-3022 (ISSN-L)
- 1421-9913
- OpenAlex
- W2070017052
- Cited by
- 51
- References
- 2
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.